FDA Adverse Event Injury Summary report: N

COULTER® LH 750 HEMATOLOGY ANALYZER

MDR report key: 2678503 · Received August 1, 2012

Report

Report Number
1061932-2012-02242
Event Type
Injury
Date Received
August 1, 2012
Date of Event
June 6, 2012
Report Date
July 5, 2012
Manufacturer
BECKMAN COULTER, INC.
Product Code
GKZ
PMA / PMN Number
K061574
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

SERVICE WAS NOT DISPATCHED TO THE SITE FOR THIS EVENT. THE COULTER LH 750 HEMATOLOGY ANALYZER DID NOT MALFUNCTION. THE EVENT WAS CAUSED BY USE ERROR. A CORRECT RESULT FROM THE INSTRUMENT WAS TAKEN BY A LABORATORY TECHNICIAN. THE CORRECT RESULT FROM INSTRUMENT WAS MANUALLY MULTIPLIED INCORRECTLY BY THE LABORATORY TECHNICIAN AND THE ERRONEOUS CALCULATED RESULT WAS REPORTED OUTSIDE THE LABORATORY.

Description of Event or Problem · 1

A CUSTOMER REPORTED THAT AN ERRONEOUS BODY FLUID (SYNOVIAL FLUID) WHITE BLOOD CELL RESULT HAD BEEN REPORTED FROM THE LABORATORY AND HAD RESULTED IN THE PATIENT RECEIVING AN UNNECESSARY ARTHROSCOPIC KNEE SURGICAL PROCEDURE. THE COULTER LH 750 HEMATOLOGY ANALYZER HAD CORRECTLY CALCULATED THE PATIENT WHITE BLOOD CELL RESULT, HOWEVER, THE LABORATORY TECHNICIAN HAS SUBSEQUENTLY MANUALLY MULTIPLIED THE RESULT INCORRECTLY AND REPORTED THE ERRONEOUSLY CALCULATED RESULT FROM THE LABORATORY. THE ERRONEOUSLY CALCULATED RESULT WAS THE IMPETUS FOR THE UNNECESSARY SURGERY. THE PATIENT OUTCOME WAS FINE WITH NO HARM TO THE PATIENT. CONTROLS WERE EXECUTED BEFORE THE INCIDENT AND WERE WITHIN THE EXPECTED RANGE. THE INSTRUMENT IS CURRENTLY PERFORMING WITHIN QC SPECIFICATIONS WITH RESPECT TO CONTROLS AND REPRODUCIBILITY. NO SPECIFIC PATIENT INFORMATION OR ADDITIONAL INSTRUMENT/PARAMETER PERFORMANCE INFORMATION WAS PROVIDED BY THE CUSTOMER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COULTER® LH 750 HEMATOLOGY ANALYZER COUNTER, DIFFERENTIAL CELL GKZ BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 Other